A detailed history of Assetmark, Inc transactions in Viatris Inc stock. As of the latest transaction made, Assetmark, Inc holds 225 shares of VTRS stock, worth $2,886. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 160 40.63%
Holding current value
$2,886
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$10.32 - $12.13 $670 - $788
65 Added 40.63%
225 $2,000
Q2 2024

Aug 13, 2024

BUY
$10.05 - $12.02 $291 - $348
29 Added 22.14%
160 $1,000
Q1 2024

May 06, 2024

SELL
$11.27 - $13.53 $1,374 - $1,650
-122 Reduced 48.22%
131 $1,000
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $1,026 - $1,269
117 Added 86.03%
253 $2,000
Q3 2023

Oct 27, 2023

BUY
$9.59 - $11.35 $326 - $385
34 Added 33.33%
136 $1,000
Q2 2023

Aug 11, 2023

SELL
$9.02 - $10.29 $460 - $524
-51 Reduced 33.33%
102 $1,000
Q1 2023

May 05, 2023

BUY
$9.2 - $12.26 $423 - $563
46 Added 42.99%
153 $1,000
Q4 2022

Feb 10, 2023

SELL
$8.72 - $11.56 $209 - $277
-24 Reduced 18.32%
107 $1,000
Q3 2022

Nov 01, 2022

SELL
$8.48 - $11.13 $695 - $912
-82 Reduced 38.5%
131 $1,000
Q2 2022

Aug 03, 2022

SELL
$9.95 - $12.27 $606 - $748
-61 Reduced 22.26%
213 $2,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $147 - $231
-15 Reduced 5.19%
274 $3,000
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $290 - $352
24 Added 9.06%
289 $4,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $715 - $817
-54 Reduced 16.93%
265 $4,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $1,530 - $1,905
-118 Reduced 27.0%
319 $5,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $5,082 - $6,933
-374 Reduced 46.12%
437 $6,000
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $11,597 - $15,198
811 New
811 $15,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.